Media

Press releases

• AlzeCure achieves Last Patient Last Visit (LPLV) in its phase II clinical trial of the non-opioid ACD440 in neuropathic pain
  March 13, 2023
• AlzeCure participates at Redeye Alzheimer Seminar on March 15
  March 7, 2023
• AlzeCure publishes its Year-end report for January – December 2022
  February 24, 2023

All press releases

Calendar

• Annual Report 2022 April 5, 2023 (Previously April 6, 2023)
• Interim report for the period January – March 2023 May 4, 2023 (Previously May 5, 2023)
• Annual General Meeting 2023 May 17, 2023

All events